Our results demonstrated that NBT blocks BC and LC metastasis through targeting MBNL2 and provided insights into the mechanism of action for the inhibitory effect of MBNL2 on metastasis. The gene discussed is MBNL2; the disease is laryngotracheoesophageal cleft.